BREAKING: Neo7Bioscience & McCullough Foundation Expose 3.5-Year Spike Persistence, Cancer Genomic Integration & mRNA Gene Chaos — Personalized Precision Peptides Restore Critically Injured Patients

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)--Neo7Bioscience, a leader in aHI-driven personalized molecular solutions, today announced compelling evidence of prolonged SARS-CoV-2 Spike protein persistence from COVID-19 infection and mRNA vaccinations, linked to genomic instability, integration events, aggressive cancers, disabilities, and multi-system injuries. This work represents a formal research collaboration between Neo7Bioscience and Dr. Peter A. McCullough, M.D., M.P.H., Nicolas Hulscher,